TIKOMED WILL BE PRESENTING IBSOLVMIR IN THE CELL AND GENE THERAPY SECTION AT BIO-EUROPE SPRING

TikoMed will be presenting IBsolvMIR at BIO-Europe in Amsterdam. IBsolvMIR is TikoMeds original project and is essentially a small molecule with protective effects from the assault from innate immune system when the cells enter the blood stream.
The drug has solid pre-clinical data and a strong safety profile.
TikoMed is now expanding its activities in the cell-therapy area and is planning for further Phase 2 studies and collaborations for various cell types and indications.

DATE
13 March 2018

TIME
TBA

VENUE
Amsterdam Palace

CITY
Amsterdam

OTHER EVENTS

TIKOMED WILL SPEAK AT BIOTECH IN EUROPE FORUM
Date: 4 October 2018 - 5 October 2018
Venue: Congress Center
Read More
TIKOMED WILL BE SENDING TEAM TO BIO-EUROPE
Date: 5 November 2018 - 7 November 2018
Venue: Bella Center
Read More
SEE MORE